Market Segmentation
- North America Opioids Product Outlook (Revenue, USD Million, 2018 - 2030)
- Immediate Release/ Short Acting Opioids
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Others
- Extended Release/Long Acting Opioids
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Others
- North America Opioids Application Outlook (Revenue, USD Million, 2018 - 2030)
- Pain Relief
- Cancer Pain
- Post-Operative Care
- Lower Back Pain
- Orthopedic
- Neuropathic
- Fibromyalgia
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Pain Relief
- North America Opioids Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Opioids Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
- Immediate Release/ Short Acting Opioids
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Others
- Extended Release/Long Acting Opioids
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Others
- Immediate Release/ Short Acting Opioids
- North America Opioids Market, Application Outlook (Revenue, USD Million, 2018 - 2030)
- Pain Relief
- Cancer Pain
- Post-Operative Care
- Lower Back Pain
- Orthopedic
- Neuropathic
- Fibromyalgia
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Pain Relief
- U.S.
- U.S. Opioids Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
- Immediate Release/ Short Acting Opioids
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Others
- Extended Release/Long Acting Opioids
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Others
- U.S. Opioids Market, Application Outlook (Revenue, USD Million, 2018 - 2030)
- Pain Relief
- Cancer Pain
- Post-Operative Care
- Lower Back Pain
- Orthopedic
- Neuropathic
- Fibromyalgia
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Pain Relief
- U.S. Opioids Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
- Canada
- Canada Opioids Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
- Immediate Release/ Short Acting Opioids
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Others
- Extended Release/Long Acting Opioids
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Others
- Immediate Release/ Short Acting Opioids
- Canada Opioids Market, Application Outlook (Revenue, USD Million, 2018 - 2030)
- Pain Relief
- Cancer Pain
- Post-Operative Care
- Lower Back Pain
- Orthopedic
- Neuropathic
- Fibromyalgia
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Pain Relief
- Canada Opioids Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
- North America Opioids Market, Product Outlook (Revenue, USD Million, 2018 - 2030)
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
